Interval-specific congenic animals for high-resolution quantitative trait loci mapping
Behavioral phenotypes (e.g., drug responses and withdrawal) are typically quantitative traits-characteristics that differ along a spectrum in the extent to which an individual possesses that characteristic. Such traits are determined by multiple genes, as well as by environmental factors and interac...
Saved in:
Published in: | Alcohol research & health Vol. 31; no. 3; pp. 266 - 269 |
---|---|
Main Authors: | , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
U.S. Government Printing Office
01-01-2008
Superintendent of Documents National Institute on Alcohol Abuse and Alcoholism |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Behavioral phenotypes (e.g., drug responses and withdrawal) are typically quantitative traits-characteristics that differ along a spectrum in the extent to which an individual possesses that characteristic. Such traits are determined by multiple genes, as well as by environmental factors and interactions among genes and environmental factors. The chromosomal regions containing these genes are commonly referred to as quantitative trait loci (QTLs). As described in the preceding article by Hitzemann and colleagues (pp. 270- 271), researchers have developed a variety of strategies to attain greater precision when mapping QTLs (Darvasi 1998; Talbot et al. 1999), which is necessary for unbiased genomewide approaches such as QTL mapping to be successful in ultimately identifying which gene(s) underlies a QTL's phenotypic influence. Among these, some approaches are clearly superior for fine mapping QTLs associated with behavioral traits. One such strategy employs specially bred animals known as interval-specific congenics (ISCs) (sometimes called small donor segment congenics). This article introduces the use of these animals in mapping QTLs associated with certain responses to alcohol. |
---|---|
Bibliography: | Deaunne L. Denmark is an M.D./Ph.D. candidate in the Neuroscience Graduate Program, Portland VA Medical Center and Oregon Health & Science University, Portland, Oregon. Lauren C. Milner is a Ph.D. candidate in the Behavioral Neuroscience Program, Portland VA Medical Center and Oregon Health & Science University, Portland, Oregon. Kari J. Buck, Ph.D., is a professor in the Department of Behavioral Neuroscience, Oregon Health & Science University and a research pharmacologist at the Portland VA Medical Center, Portland, Oregon. |
ISSN: | 1535-7414 2168-3492 1930-0573 2169-4796 |